Mirae Asset Global Investments Co., Ltd. Harmony Biosciences Holdings, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $37.3 Billion
- Q1 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,919 shares of HRMY stock, worth $57,493. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,919
Previous 1,900
1.0%
Holding current value
$57,493
Previous $65,000
3.08%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding HRMY
# of Institutions
262Shares Held
45.7MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$198 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$175 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$142 Million0.0% of portfolio
-
State Street Corp Boston, MA1.58MShares$47.4 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT1.45MShares$43.4 Million2.2% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.77B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...